PORTSMOUTH, New Hampshire, USA, September 17, 2021 – Cyclyx International, a consortium-based feedstock management company with a mission to increase the recycling rate of plastic from 10% to 90%, has announced MilliporeSigma has joined the consortium as the newest founding member. MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company and supplier to the global life science industry.
MilliporeSigma, the first Cyclyx member representing the life science industry, integrates a focus on sustainability throughout all phases of the product life cycle to continuously introduce innovation in the form of greener product alternatives, more sustainable packaging and distribution, and expanded recycling and reuse programs. MilliporeSigma has worked together with customers and the waste management industry to provide a first-of-its kind single-stream recycling program for Biopharma single-use technologies, resulting in more than 6,500 tons recycled since 2015.
As a member of the consortium, MilliporeSigma will extend its leadership and expertise in sustainability while continuing to build a more circular economy for its products. In addition, MilliporeSigma will take an active role in helping Cyclyx to expand its programs by having Jacqueline Hollands, global manager of product recycling and innovation for MilliporeSigma, serve on the Cyclyx executive advisory board.
“We are pleased to welcome MilliporeSigma as our newest founding member and to have Ms. Hollands lend her expertise to the executive advisory board,” stated Joe Vaillancourt, CEO of Cyclyx. “As the consortium expands to new sectors, counting industry leaders such as MilliporeSigma among our members demonstrates that the benefit of our programs stretches across the value chain. These new memberships are critical in driving the success of our mission to increase recycling rates from 10% to 90%.”
“MilliporeSigma collaborates with our customers and the waste management industry to provide first-of-its-kind recycling programs, and we are excited to continue this important work as a founding member of Cyclyx,” said Jeffrey Whitford, Head of Sustainability and Social Business Innovation at the life science business of Merck KGaA, Darmstadt, Germany. “Finding high-value uses for materials, including those that come from recycling programs, is key not only for us, but for our customers in the life science industry. Tapping into Cyclcx’s capability to create programs that drive single-use plastics from the life science industry back into the value chain will go a long way to helping solve some of the world’s most difficult challenges.”
Contacts
Kate Ringier
Cyclyx
VP, Communications & Government Affairs
+41 78 822 7770
kate.ringier@agilyx.com
About Cyclyx International, LLC.
Cyclyx International, LLC. (“Cyclyx”) is a post-use plastic feedstock management company working with industry participants to develop innovative recycling solutions for all types of post-use plastics. The company’s mission is to help increase the recycling rate of plastics from 10% to 90% by using Cyclyx’s expertise in understanding the chemical composition of post-use plastic in collaboration with industry partners to create a new, innovative supply chain. Cyclyx was founded by Agilyx Corporation (“Agilyx”), a leader in advanced chemical recycling, together with ExxonMobil Chemical Company, one of the largest chemical companies in the world. Cyclyx has been formed to be a consortium-based entity and since its founding there have been a growing number of companies joining its membership. For more information, visit us at www.cyclyx.com.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 22,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing, and testing services.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science, and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.